John Theurer Cancer Center at Hackensack University Med Ctr ( Site 0002) is a clinical research site located in Hackensack, New Jersey, United States 07601.
Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.
John Theurer Cancer Center at Hackensack University Med Ctr ( Site 0002) has participated in 1 clinical trials.
Therapeutic areas: Triple-negative Breast Cancer, Non-squamous Non-small-cell Lung Cancer, NSCLC.
Sponsors: VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).
Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
John Theurer Cancer Center at Hackensack University Med Ctr ( Site 0002) has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
John Theurer Cancer Center at Hackensack University Med Ctr ( Site 0002) has 1 clinical trials on record. Their work covers Triple-negative Breast Cancer, Non-squamous Non-small-cell Lung Cancer, NSCLC.
John Theurer Cancer Center at Hackensack University Med Ctr ( Site 0002) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.